The Pharma Fast 50
PharmaTimes presents Alantra’s annual ranking of the fastest growing private pharma companies in the UK
In 2020 the world turned upside-down and the pharma sector was no exception. As COVID-19 spread globally and lockdowns took effect, the industry responded with a surge of adaptability, resilience and innovation.
This response is borne from the key trait we see every year in the constituents of the Alantra Pharma Fast 50, our annual ranking of the 50 fastest-growing privately owned pharmaceutical businesses in the UK. The common theme among these businesses is a relentless focus on innovation.
There has never been more public attention on what it takes to deliver an effective drug to patients than over the last 12 months. The businesses in the Pharma Fast 50 touch on every element of that – from early stage research right through to ensuring vital medicines continue to flow across borders. Some are using artificial intelligence (AI) to identify and design
by Stephen Chapman
The agency, which is based in Alderley Park, already has a second office in Oxfordshire.
It stated that the private equity funds will help it launch a third base in the centre of Manchester as it “evaluates options” for future international expansion.
“Despite some of the broader challenges in 2020, we’ve enjoyed another excellent year. The business continues to go from strength to strength and that is all down to the people and expertise that we have in our growing team,” said Andrew Minnock, Managing Director of Helios.
“From the outset, NorthEdge recognised the importance of the positive culture we have developed, which makes them the ideal partner to support our next phase of growth. We are continuing to recruit top talent in the UK to support global client demand, as well as launching offices internationally to enhance our global footprint. Having NorthEdge’s expertise and support on that journey will be invaluable.”